Stockreport

Deciphera Pharmaceuticals, Inc. and Zai Lab Limited Announce an Exclusive License Agreement for Ripretinib in Greater China

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations
PDF - Zai Lab to Lead the Development and Commercialization of Ripretinib in Greater China - - Deciphera To Receive $20 Million Upfront Cash Payment, [Read more]